Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer

Abstract

m6A RNA modification modulated gene expression and thereby affected clinicopathological features and survival outcomes in BC. CBLL1 may be a promising prognostic biomarker for BC patients.